You just read:

Ortho Clinical Diagnostics and Sphingotec Announce Strategic Agreement Regarding Novel Biomarker for Decreasing Re-hospitalizations in Heart Failure

News provided by

Ortho Clinical Diagnostics

Dec 07, 2017, 07:30 ET